Prudential Financial’s Sana Biotechnology SANA Stock Holding History

Prudential Financial’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.8K	Buy	+25,265	New	+$99.5K	﹤0.01%	2269
2025 Q4	–	Sell	-16,860	Closed	-$59.9K	–	2411
2025 Q3	$59.9K	Sell	16,860 -1,400	-8%	-$5.06K	﹤0.01%	2323
2025 Q2	$49.9K	Buy	+18,260	New	+$37.7K	﹤0.01%	2346
2024 Q2	–	Sell	-13,350	Closed	-$134K	–	2772
2024 Q1	$134K	Buy	+13,350	New	+$100K	﹤0.01%	2504

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Prudential Financial's SANA Position: Q1 2026 in Review

Prudential Financial opened a new position in Sana Biotechnology (SANA) in Q1 2026: 25,265 shares worth $72.8K. The stake represents ﹤0.01% of the portfolio and ranks #2269 among its holdings. This is a return to the name: Prudential Financial previously reported a position in SANA as recently as Q3 2025.

Prudential Financial first reported a position in SANA in Q1 2024 and has held it in 4 quarters since. The position peaked at $134K in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Prudential Financial held 25,265 shares of Sana Biotechnology worth $72.8K as of Q1 2026.
Sana Biotechnology was a new Prudential Financial position in Q1 2026.
Sana Biotechnology made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2269 holding.
Prudential Financial first reported a position in Sana Biotechnology in Q1 2024 and has held it in 4 quarters since.
Prudential Financial's Sana Biotechnology position peaked at $134K in Q1 2024.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.